1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-08-17 pm EDT
158.00 USD   -5.93%
08/17US Stocks Close Lower Wednesday After Retail Sales Data, Fed Meeting Minutes
MT
08/17Health Care Down as Rebound Runs out of Steam - Health Care Roundup
DJ
08/17US Stocks Close Lower Wednesday After Retail Sales Data, Fed Meeting Minutes
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Moderna

06/27/2022 | 07:14am EDT


© MT Newswires 2022
All news about MODERNA, INC.
08/17US Stocks Close Lower Wednesday After Retail Sales Data, Fed Meeting Minutes
MT
08/17Health Care Down as Rebound Runs out of Steam - Health Care Roundup
DJ
08/17US Stocks Close Lower Wednesday After Retail Sales Data, Fed Meeting Minutes
MT
08/17MODERNA : JAMES MOCK JOINS MODERNA AS CHIEF FINANCIAL OFFICER - Form 8-K
PU
08/17MODERNA, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Finan..
AQ
08/17Moderna Discloses New CFO Mock's Pay
DJ
08/17Top Midday Decliners
MT
08/17Equities Drop Midday After Flat July Retail Sales Print; Traders Wait for Fed Minutes
MT
08/17MIDDAY REPORT : US Stocks Drop, Treasury Yields Jump Amid Flat Retail Sales in July
MT
08/17Moderna, PerkinElmer Name New Financial Chiefs
DJ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 21 892 M - -
Net income 2022 11 063 M - -
Net cash 2022 16 818 M - -
P/E ratio 2022 5,98x
Yield 2022 -
Capitalization 61 810 M 61 810 M -
EV / Sales 2022 2,06x
EV / Sales 2023 4,07x
Nbr of Employees 2 700
Free-Float 90,4%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 158,00 $
Average target price 214,00 $
Spread / Average Target 35,4%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-37.79%61 810
IQVIA HOLDINGS INC.-13.27%45 640
LONZA GROUP AG-26.68%43 587
SEAGEN INC.10.47%31 450
ALNYLAM PHARMACEUTICALS, INC.31.58%27 384
CELLTRION, INC.7.07%22 159